Gaeta G B, Tripodi M F
Naunyn Schmiedebergs Arch Pharmacol. 1987 Jun;335(6):697-700. doi: 10.1007/BF00166989.
The effects of ketoconazole (KT) on the hepatic excretory function was investigated in the isolated perfused rat liver. KT, at the concentrations of 5 X 10(-5) M or 10(-4) M caused dose-dependent decreases of the biliary bile acid concentration and excretion rate, with no significant effect on bile flow rates. Neither dose altered perfusate flow through the liver. Furthermore, at the same two concentrations, KT impaired the sulfobromophthalein transport in a dose-dependent manner. In contrast, the drug did not alter 14C-sucrose bile to perfusate ratio and did not cause enzyme release from the liver into the perfusate. The study demonstrates that KT possesses an intrinsic toxicity in the isolated perfused rat liver and suggests caution in the use of this drug in hepatopathic patients.
在离体灌注大鼠肝脏中研究了酮康唑(KT)对肝脏排泄功能的影响。浓度为5×10⁻⁵ M或10⁻⁴ M的KT导致胆汁中胆汁酸浓度和排泄率呈剂量依赖性降低,而对胆汁流速无显著影响。两种剂量均未改变流经肝脏的灌注液流速。此外,在相同的这两种浓度下,KT以剂量依赖性方式损害磺溴酞钠转运。相比之下,该药物未改变14C-蔗糖从胆汁到灌注液的比率,也未导致酶从肝脏释放到灌注液中。该研究表明,KT在离体灌注大鼠肝脏中具有内在毒性,并提示在肝病患者中使用该药物时应谨慎。